Happy Thanksgiving Y’all! 

This has been a tough year for pharmaceutical companies, with price concerns on the tip of everyone’s tongue, the race to the bottom on generic drug pricing and its impact on drug shortages, FDA now back almost fully in the facility inspection mode, Warning Letters flying out of the Agency at a breakneck pace, and […]

Read More